Companies: 10,795·Total market cap: $144.5T

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

BCLIOTCHealthcare● Active

$0.78

+$0.03(+4.46%)

Market Cap$8629194

P/E Ratio—

52W High$1.33

52W Low$0.46

Avg Volume14K

Open$0.74

Beta0.28

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Brainstorm Cell Therapeutics Inc.（BCLI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BCLI · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.94Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding9.3MShares outstanding history

Next EarningsAug 17, 2026Est.Earnings history

探索 Brainstorm Cell Therapeutics Inc. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-1.11-150.68%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$10.3M▼ 188.68% YoY

202320242025

FY 2025EPS$-1.11▼ 150.68% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$9.6MEPS: $-0.94View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.78Current

$—Avg Target

$—High

合计: 3 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Brainstorm Cell Therapeutics Inc.

$0.78+4.46%$8.6M #2

Acurx Pharmaceuticals, Inc.

$1.64-2.98%$2.6M #3

Adial Pharmaceuticals, Inc.

$2.27+1.58%$2.2M #4

Addex Therapeutics Ltd

$6.40+9.39%$4.6M #5

BioCardia, Inc.

$0.91-11.35%$5.3M #6

Cardio Diagnostics Holdings, Inc.

$1.93-0.64%$4.0M

股票表现

1D+6.87%

1W+5.10%

1M+15.18%

3M+12.68%

YTD+45.45%

1Y-35.48%

5Y-98.58%

关于 Brainstorm Cell Therapeutics Inc.

CEOChaim Lebovits

IPO DateOct 7, 2003

Employees27

CountryUS

Websitebrainstorm-cell.com

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The compa…

Biotechnology HealthcareOTCUS

关于股票概览与关键数据

Brainstorm Cell Therapeutics Inc.（BCLI）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 7, 2003 在 OTC 上市。截至最近交易日，BCLI 股价为 $0.78，市值约为 $8.8M。过去12个月累计回报 -35.48%，年初至今回报 +45.45%。

根据 3 位华尔街分析师，Brainstorm Cell Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Brainstorm Cell Therapeutics Inc. 营收 —，净利润 -$10.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Brainstorm Cell Therapeutics Inc.（BCLI）股价为 $0.78，在 OTC 上市，52周区间为 $0.46 – $1.33。

BCLI 最新股价BCLI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议